Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Business News/Market/Market Stats/Glaxosmithkline Pharmaceuticals share price/ Glaxosmithkline Pharmaceuticals Profit Loss Annual
Glaxosmithkline Pharmaceuticals Profit & Loss Annual
Trade2,345.90 -69.30 (-2.87%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 3,453.71 | 3,251.72 | 3,278.03 | 2,925.60 |
| Total Revenue | 3,453.71 | 3,251.72 | 3,278.03 | 2,925.60 |
| Costof Revenue Total | 1,334.53 | 1,394.28 | 1,482.14 | 1,368.00 |
| Gross Profit | 2,119.18 | 1,857.44 | 1,795.89 | 1,557.61 |
| Selling/ General/ Admin Expenses Total | 624.39 | 991.00 | 981.82 | 890.82 |
| Depreciation/ Amortization | 69.68 | 65.62 | 68.04 | 78.46 |
| Unusual Expense( Income) | 163.31 | 10.61 | 19.82 | 174.44 |
| Other Operating Expenses Total | 586.10 | 52.24 | 47.06 | 68.58 |
| Total Operating Expense | 2,778.01 | 2,513.91 | 2,599.03 | 2,580.44 |
| Operating Income | 675.70 | 737.81 | 679.00 | 345.16 |
| Interest Inc( Exp) Net- Non- Op Total | -18.00 | 892.85 | 648.73 | 1,073.93 |
| Gain( Loss)on Saleof Assets | 197.00 | 96.72 | 317.24 | 17.82 |
| Other Net | 122.59 | -0.37 | 3.45 | -0.34 |
| Net Income Before Taxes | 816.19 | 836.40 | 779.05 | 453.99 |
| Provisionfor Income Taxes | 226.23 | 228.76 | 398.28 | 166.72 |
| Net Income After Taxes | 589.96 | 607.64 | 380.77 | 287.27 |
| Net Income Before Extra Items | 589.96 | 607.64 | 380.77 | 287.27 |
| Total Extraordinary Items | 0.00 | 3.04 | 1,313.95 | 70.88 |
| Net Income | 589.96 | 610.69 | 1,694.72 | 358.15 |
| Income Availableto Com Excl Extra Ord | 589.96 | 607.64 | 380.77 | 287.27 |
| Income Availableto Com Incl Extra Ord | 589.96 | 610.69 | 1,694.72 | 358.15 |
| Diluted Net Income | 589.96 | 610.69 | 1,694.72 | 358.15 |
| Diluted Weighted Average Shares | 16.94 | 16.94 | 16.94 | 16.94 |
| Diluted EPS Excluding Extra Ord Items | 34.83 | 35.87 | 22.48 | 16.96 |
| Diluted Normalized EPS | 40.96 | 35.91 | 22.13 | 23.41 |
| Interest Exp( Inc) Net- Operating Total | - | 1.44 | 1.44 | 1.44 |
| DPS- Common Stock Primary Issue | - | 32.00 | 30.00 | 30.00 |
*All figures in crores except per share values
Glaxosmithkline Pharmaceuticals Quick Links
Glaxosmithkline Pharmaceuticals Dividend Glaxosmithkline Pharmaceuticals Bonus Glaxosmithkline Pharmaceuticals News Glaxosmithkline Pharmaceuticals AGM Glaxosmithkline Pharmaceuticals Rights Glaxosmithkline Pharmaceuticals Splits Glaxosmithkline Pharmaceuticals Board Meetings Glaxosmithkline Pharmaceuticals Key Metrics Glaxosmithkline Pharmaceuticals Shareholdings Glaxosmithkline Pharmaceuticals Balance Sheet Glaxosmithkline Pharmaceuticals Cashflow Glaxosmithkline Pharmaceuticals Q1 Results Glaxosmithkline Pharmaceuticals Q2 Results Glaxosmithkline Pharmaceuticals Q3 Results Glaxosmithkline Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)